Earnings Reportpositive

Earnings Report

Other upcoming events for COGT

Phase 3 ReadoutPhase 3 Topline: A Phase 3 Randomized, Open-Label, Multicenter Clinical Study of CGT9486+Sunitinib vs. Sunitinib in S

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Earnings Report — COGT Earnings Report | BioSniper